Ledger.Open graph →

SEC Form D · Amendment · filed January 14, 2020

Valanbio Therapeutics, Inc

Offering

$600K

Sold

$421K

Exemption

Rule 506(b)

Industry

Pharmaceuticals

Location

RALEIGH, NC

Type

—

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (15)

Clayton Duncan · Raleigh, NCExec · Director Pei J. Zhou · Raleigh, NCExec · Director Moise A. Khayrallah · Raleigh, NCExec · Director Eric J. Toone · Raleigh, NCDirector Sam Hopkins · Raleigh, NCDirector Artis Kehris · WILMINGTON, DEExec · Director Janis Berdigans · WILMINGTON, DEDirector Dino Becirovic · WILMINGTON, DEDirector Ravi Inukonda · WILMINGTON, DEExec · Director Lauris Lietavietis · WILMINGTON, DEExec · Director Catherine S. Cawthon · COLUMBUS, OHExec · Director Grady P. Appleton · COLUMBUS, OHExec · Director Dennis S. Guest · COLUMBUS, OHExec · Director Jeanne P. Golliher · COLUMBUS, OHDirector Harold D. Keller · COLUMBUS, OHDirector

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗